Prime Movers Lab leads $15m round for Elevian

Massachusetts-based Elevian, a developer of medicines focused on multiple age-related diseases, has secured $15 million in financing.

25 November 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles